Summary
referring to Ventritex's right to assert the Section 271(e) defense
Summary of this case from Amgen, Inc. v. F. Hoffman-LaRoche Ltd.Opinion
No. 92-1076.
February 22, 1993
D.Ct./N.D.Cal., 775 F.Supp. 1269.
AFFIRMED.
From Casetext: Smarter Legal Research
Intermedics, Inc. v. Ventritex, Inc.
United States Court of Appeals, Federal Circuit
Feb 22, 1993
991 F.2d 808 (Fed. Cir. 1993)
Summaries of
Intermedics, Inc. v. Ventritex, Inc.
United States Court of Appeals, Federal Circuit
Feb 22, 1993
991 F.2d 808 (Fed. Cir. 1993)
referring to Ventritex's right to assert the Section 271(e) defense
Summary of this case from Amgen, Inc. v. F. Hoffman-LaRoche Ltd.Case details for
Intermedics, Inc. v. Ventritex, Inc.
Case Details
Full title:Intermedics , Inc. v. Ventritex, Inc
Court:United States Court of Appeals, Federal Circuit
Date published: Feb 22, 1993
Citations
991 F.2d 808 (Fed. Cir. 1993)
Citing Cases
Amgen Inc. v. Hospira, Inc.
Hospira's citations to other cases quote language clarifying that the mere existence of some intent,…
Abbott Laboratories v. Zenith Laboratories, Inc.The FDA has not given Defendant approval to market a generic form of HYTRIN and the fact that Defendant has…